These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 15756449

  • 1. The prognostic value of overexpression of Skp2 mRNA in non-small cell lung cancer.
    Takanami I.
    Oncol Rep; 2005 Apr; 13(4):727-31. PubMed ID: 15756449
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis.
    Takanami I.
    Oncol Rep; 2004 Oct; 12(4):849-53. PubMed ID: 15375511
    [Abstract] [Full Text] [Related]

  • 3. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
    Wu YH, Cheng YW, Chang JT, Wu TC, Chen CY, Lee H.
    Cancer; 2007 Jul 01; 110(1):215-23. PubMed ID: 17508409
    [Abstract] [Full Text] [Related]

  • 4. Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer.
    Osoegawa A, Yoshino I, Tanaka S, Sugio K, Kameyama T, Yamaguchi M, Maehara Y.
    J Clin Oncol; 2004 Oct 15; 22(20):4165-73. PubMed ID: 15483027
    [Abstract] [Full Text] [Related]

  • 5. Significance of skp2 expression in primary breast cancer.
    Sonoda H, Inoue H, Ogawa K, Utsunomiya T, Masuda TA, Mori M.
    Clin Cancer Res; 2006 Feb 15; 12(4):1215-20. PubMed ID: 16489076
    [Abstract] [Full Text] [Related]

  • 6. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.
    Zhang L, Chen J, Ke Y, Mansel RE, Jiang WG.
    Int J Mol Med; 2006 May 15; 17(5):937-44. PubMed ID: 16596284
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH, Wang SF, Yu L, Wang J, Chang H, Yan WL, Zhang J, Fu K.
    Lung Cancer; 2008 Oct 15; 62(1):113-9. PubMed ID: 18550205
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of Jun activation domain-binding protein 1 in nonsmall cell lung cancer and its significance in p27 expression and clinical features.
    Osoegawa A, Yoshino I, Kometani T, Yamaguchi M, Kameyama T, Yohena T, Maehara Y.
    Cancer; 2006 Jul 01; 107(1):154-61. PubMed ID: 16721818
    [Abstract] [Full Text] [Related]

  • 9. Skp2 overexpression is a prognostic factor in patients with ovarian adenocarcinoma.
    Shigemasa K, Gu L, O'Brien TJ, Ohama K.
    Clin Cancer Res; 2003 May 01; 9(5):1756-63. PubMed ID: 12738731
    [Abstract] [Full Text] [Related]

  • 10. [Expression of SKP2 protein in lung carcinoma and its implication for prognosis].
    Zhao J, Yang CL, Zhao SY.
    Zhonghua Zhong Liu Za Zhi; 2007 Apr 01; 29(4):289-92. PubMed ID: 17760257
    [Abstract] [Full Text] [Related]

  • 11. The diagnostic and prognostic relevance of human telomerase reverse transcriptase mRNA expression detected in situ in patients with nonsmall cell lung carcinoma.
    Fujita Y, Fujikane T, Fujiuchi S, Nishigaki Y, Yamazaki Y, Nagase A, Shimizu T, Ohsaki Y, Kikuchi K.
    Cancer; 2003 Sep 01; 98(5):1008-13. PubMed ID: 12942569
    [Abstract] [Full Text] [Related]

  • 12. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.
    Tsai MF, Wang CC, Chang GC, Chen CY, Chen HY, Cheng CL, Yang YP, Wu CY, Shih FY, Liu CC, Lin HP, Jou YS, Lin SC, Lin CW, Chen WJ, Chan WK, Chen JJ, Yang PC.
    J Natl Cancer Inst; 2006 Jun 21; 98(12):825-38. PubMed ID: 16788156
    [Abstract] [Full Text] [Related]

  • 13. Increased expression of SKP2 and phospho-MAPK/ERK1/2 and decreased expression of p27 during tumor progression of cervical neoplasms.
    Chen TP, Chen CM, Chang HW, Wang JS, Chang WC, Hsu SI, Cho CL.
    Gynecol Oncol; 2007 Mar 21; 104(3):516-23. PubMed ID: 17079005
    [Abstract] [Full Text] [Related]

  • 14. High expression of S-phase kinase-associated protein 2 (Skp2) is a strong prognostic marker in oral squamous cell carcinoma patients treated by UFT in combination with radiation.
    Harada K, Supriatno, Kawaguchi S, Kawashima Y, Itashiki Y, Yoshida H, Sato M.
    Anticancer Res; 2005 Mar 21; 25(3c):2471-5. PubMed ID: 16080478
    [Abstract] [Full Text] [Related]

  • 15. S-phase kinase-associated protein 2 expression in laryngeal squamous cell carcinomas and its prognostic implications.
    Dong Y, Sui L, Watanabe Y, Sugimoto K, Tokuda M.
    Oncol Rep; 2003 Mar 21; 10(2):321-5. PubMed ID: 12579266
    [Abstract] [Full Text] [Related]

  • 16. CK19 mRNA expression measured by reverse-transcription polymerase chain reaction (RT-PCR) in the peripheral blood of patients with non-small cell lung cancer treated by chemo-radiation: an independent prognostic factor.
    Chen TF, Jiang GL, Fu XL, Wang LJ, Qian H, Wu KL, Zhao S.
    Lung Cancer; 2007 Apr 21; 56(1):105-14. PubMed ID: 17166620
    [Abstract] [Full Text] [Related]

  • 17. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
    Liao WT, Wang X, Xu LH, Kong QL, Yu CP, Li MZ, Shi L, Zeng MS, Song LB.
    Cancer; 2009 Apr 01; 115(7):1507-17. PubMed ID: 19170237
    [Abstract] [Full Text] [Related]

  • 18. Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients.
    Li R, An SJ, Chen ZH, Zhang GC, Zhu JQ, Nie Q, Xie Z, Guo AL, Mok TS, Wu YL.
    Hum Pathol; 2008 Dec 01; 39(12):1792-801. PubMed ID: 18715616
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer.
    Hsu NY, Ho HC, Chow KC, Lin TY, Shih CS, Wang LS, Tsai CM.
    Cancer Res; 2001 Mar 15; 61(6):2727-31. PubMed ID: 11289154
    [Abstract] [Full Text] [Related]

  • 20. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer.
    Takizawa H, Kondo K, Fujino H, Kenzaki K, Miyoshi T, Sakiyama S, Tangoku A.
    Br J Cancer; 2006 Jul 03; 95(1):75-9. PubMed ID: 16755294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.